Skip to main content
Caplight Logo









Macrolide Pharmaceuticals

Macrolide Pharmaceuticals

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://macrolidetx.com

Last Round

Series B

Apr 2, 2018

Total Funding Raised

$42M

Company Overview

Macrolide Pharmaceuticals is a biotechnology company that develops novel, fully synthetic macrolide antibiotics to treat life-threatening, multi-drug resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

macrolide antibioticssynthetic chemistryantibiotic resistancedrug discoverymultidrug-resistant bacteriasuperbugsGram-negative bacteriacomplicated urinary tract infectionscUTIpreclinical biopharmaantibiotic developmentbiotechmedicinal chemistrynon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Macrolide Pharmaceuticals Comparables

Compare Macrolide Pharmaceuticals with similar companies based on industry and business-model similarity.

Macrolide Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kinvard Bio
83%
smartbax GmbH
80%
MyxoBiomedical
79%

Macrolide Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 2, 2018
GrantMar 1, 2018
Series AMar 4, 2015

Macrolide Pharmaceuticals Investors

Notable investors and investment history

Macrolide Pharmaceuticals investors
InvestorRounds
Roche Venture FundSeries B, Series A
CARB-XGrant
Gurnet Point CapitalSeries A
SR OneSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2018

    $20M round with participation from Novartis and SR One.

  • Mar 1, 2018

    Received $2.44M in grant funding from CARB-X.

Macrolide Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Macrolide Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Macrolide Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Year Founded2015
Last FundingApr 2, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?